Therapeutic strategies for soft tissue malignancies in adults. Results of the CAD soft tissue tumor register study and approaches to improvement in quality of treatment
T. Junginger et al., Therapeutic strategies for soft tissue malignancies in adults. Results of the CAD soft tissue tumor register study and approaches to improvement in quality of treatment, CHIRURG, 72(2), 2001, pp. 138-148
Introduction: This study, carried out by the Surgical Oncology Working Grou
p (CAO) of the German Society for Surgery was performed to analyse the stra
tegies in the treatment of soft tissue sarcomas in adults. Methods: In a pe
riod of 19 months the data on 292 patients suffering from soft tissue sarco
mas, treated in 99 surgical departments in Germany, were analysed prospecti
vely. A special questionnaire was developed including pretherapeutic biopsy
, previous treatment, definitive surgical treatment, combined modality appr
oach and histopathological results. Results: Thirty-nine per cent of the tu
mours were treated in university hospitals, 36% in medical centres, 24% in
regional hospitals. During the observation period two patients were treated
on average (median) by each hospital. Limb-sparing treatment was performed
in 96% of the extremity tumours. There was no significant difference in th
e frequency of RO resections between the different hospitals. At the univer
sity hospitals local extended operations and additive measures were used mo
re often. The indication for adjuvant radiotherapy differed: after compartm
ental resection, adjuvant radiotherapy was performed in 39% of cases (19/49
); after wide-excision of high-grade tumours, in 45% of cases (20/44) no ad
juvant radiotherapy was necessary. In spite of less radical treatment in tu
mours of the trunk, additional radiotherapy was not more frequently perform
ed. Conclusion: To improve the quality in the treatment of soft tissue sarc
omas it seems to be of great importance to avoid inadequate initial treatme
nt (18%), to respect the rules of oncological surgery (tumour rupture in 7%
of cases), to improve the histopathological examination (no R classificati
on in 5-12%) and to develop guidelines for multimodality treatment.